Low rates of mutation in clinical grade human pluripotent stem cells under different culture conditions
Open Access
- 23 March 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Communications
- Vol. 11 (1), 1-14
- https://doi.org/10.1038/s41467-020-15271-3
Abstract
The occurrence of repetitive genomic changes that provide a selective growth advantage in pluripotent stem cells is of concern for their clinical application. However, the effect of different culture conditions on the underlying mutation rate is unknown. Here we show that the mutation rate in two human embryonic stem cell lines derived and banked for clinical application is low and not substantially affected by culture with Rho Kinase inhibitor, commonly used in their routine maintenance. However, the mutation rate is reduced by >50% in cells cultured under 5% oxygen, when we also found alterations in imprint methylation and reversible DNA hypomethylation. Mutations are evenly distributed across the chromosomes, except for a slight increase on the X-chromosome, and an elevation in intergenic regions suggesting that chromatin structure may affect mutation rate. Overall the results suggest that pluripotent stem cells are not subject to unusually high rates of genetic or epigenetic alterations.This publication has 53 references indexed in Scilit:
- BCL-XL Mediates the Strong Selective Advantage of a 20q11.21 Amplification Commonly Found in Human Embryonic Stem Cell CulturesStem Cell Reports, 2013
- FGF Signaling Inhibition in ESCs Drives Rapid Genome-wide Demethylation to the Epigenetic Ground State of PluripotencyCell Stem Cell, 2013
- Signatures of mutational processes in human cancerNature, 2013
- Mutational Processes Molding the Genomes of 21 Breast CancersCell, 2012
- Erosion of Dosage Compensation Impacts Human iPSC Disease ModelingCell Stem Cell, 2012
- Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantageNature Biotechnology, 2011
- Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applicationsBioinformatics, 2011
- A comprehensive catalogue of somatic mutations from a human cancer genomeNature, 2009
- The role of oxygen availability in embryonic development and stem cell functionNature Reviews Molecular Cell Biology, 2008
- A ROCK inhibitor permits survival of dissociated human embryonic stem cellsNature Biotechnology, 2007